Back to search
Leukemia, Lymphoblastic, Acute, Pediatric
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Leukemia, Lymphoblastic, Acute, Pediatric trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Leukemia, Lymphoblastic, Acute, Pediatric trials you may qualify forPlain Language Summary: Background Glucocorticoids are stress hormones produced by the human body to control inflammation and regulate the immune system. Corti…
Background: Chimeric antigen receptor T-cell (CART) therapy is a form of immunotherapy which can be used to treat people with relapsed B-ALL. For those who ach…
Acute lymphoblastic leukemia is the most common type of cancer in children diagnosed between the ages of two and five. After cancer treatment, children suffer f…
This study is a phase I study designed to evaluate the safety of CD19-CD22-CAR T cells. Primary Objective: To determine the safety profile and propose the rec…
This study aims to use clinical and biological characteristics of acute leukemias to screen for patient eligibility for available pediatric leukemia sub-trials.…
To assess the efficacy of using mobile technology to improve the percentage of time wherein drug dosing is within the target range
This pilot study will primarily be evaluated by feasibility and adherence to an iPad-based neurocognitive intervention program. It will secondarily be evaluated…
Study of QUAIL-100 in Patients With High Risk Acute Leukemia and Myelodysplastic Syndrome Who Have Received Hematopoietic Stem Cell Transplant
The purpose of this study is to see if conditioning regimens that include personalized rabbit ATG (P-rATG) help the immune system recover sooner and decrease th…